Callitas Health Welcomes Brian D. Keane as Capital Markets and Merger and Acquisitions Consultant

Author's Avatar
May 28, 2019
Article's Main Image

CINCINNATI, OH / ACCESSWIRE / May 28, 2019 / Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the "Company" or "Callitas") a clinical-stage pharmaceutical development, OTC consumer goods marketing and cannabis delivery development company, today announced that Brian D. Keane will join the team as the Company's Capital Markets and Merger and Acquisitions Consultant. The addition of Brian to the team will allow Callitas to continue focus on its patented wellness technology delivery platform and continued expansion into the global cannabis marketplace.